knowledge -WSS

knowledge

author：focus 2025-09-29 22:47:47 - browse：319

The FDA building -- First Opinion coverage from STAT — Adobe

The clearance of a first-of-its-kind cancer treatment made by Amgen is on shakier ground following a Food and Drug Administration advisory committee meeting Thursday.

Regulatory advisers voted 10-2 that the data on the company’s drug Lumakras, a treatment for lung cancer, could not be properly assessed. Lumakras targets a specific mutation to a protein called KRAS, which is one of the most common genetic mutations in cancer.

The vote comes as Amgen is hoping to convert a conditional approval for the drug to a full approval based on a 345-person study called CodeBreaK 200, in which Lumakras met the primary endpoint, delaying tumor growth approximately five weeks longer than the standard of care medication, docetaxel. The drug didn’t extend patients’ overall survival.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Addiction doctors spar with methadone clinics over legislation

focus

leisure time

WSS

Women's World Cup brings attention to abuse in soccer

One Duchenne patient's bittersweet hope for new treatment

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Addiction doctors spar with methadone clinics over legislation

Focused ultrasound for uterine fibroids: an uphill battle

Wikipedia

knowledge

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Scientists successfully use ultrasound imaging to map brain activity

Peter Hotez and the public health issue of online harassment

Addiction doctors spar with methadone clinics over legislation

Wildfire smoke exposes gaps in outdoor worker protections

Adam's Biotech Scorecard: Do Sarepta's exon

Virginia high school admissions case could be legal follow

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

focus

Watch the official trailer for 'Ahsoka' series

David Sabatini, ex

Inflation cooled significantly in June, bringing price hikes close to normal levels

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Scientists successfully use ultrasound imaging to map brain activity

hotspot

focus

leisure time

entertainment